Cargando…
Treatment response and disease progression
This tutorial defines the concepts of disease progression in the context of clinical pharmacology. Disease progression describes the natural history of disease, such as pain, or biomarker of drug response, such as blood pressure. The action of a drug, such as inhibiting an enzyme or activating a rec...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032964/ https://www.ncbi.nlm.nih.gov/pubmed/32095479 http://dx.doi.org/10.12793/tcp.2019.27.4.123 |
_version_ | 1783499569100750848 |
---|---|
author | Holford, Nick |
author_facet | Holford, Nick |
author_sort | Holford, Nick |
collection | PubMed |
description | This tutorial defines the concepts of disease progression in the context of clinical pharmacology. Disease progression describes the natural history of disease, such as pain, or biomarker of drug response, such as blood pressure. The action of a drug, such as inhibiting an enzyme or activating a receptor, leads to a change in disease status over time. Two main types of drug response can be defined based on the pattern of the time course of disease status. The most common is a symptomatic effect equivalent to a shift up or down of the natural history curve. Less common but quite clinically important is a disease-modifying effect equivalent to a change in the rate of disease progression. |
format | Online Article Text |
id | pubmed-7032964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Korean Society for Clinical Pharmacology and Therapeutics |
record_format | MEDLINE/PubMed |
spelling | pubmed-70329642020-02-24 Treatment response and disease progression Holford, Nick Transl Clin Pharmacol Tutorial This tutorial defines the concepts of disease progression in the context of clinical pharmacology. Disease progression describes the natural history of disease, such as pain, or biomarker of drug response, such as blood pressure. The action of a drug, such as inhibiting an enzyme or activating a receptor, leads to a change in disease status over time. Two main types of drug response can be defined based on the pattern of the time course of disease status. The most common is a symptomatic effect equivalent to a shift up or down of the natural history curve. Less common but quite clinically important is a disease-modifying effect equivalent to a change in the rate of disease progression. Korean Society for Clinical Pharmacology and Therapeutics 2019-12 2019-12-31 /pmc/articles/PMC7032964/ /pubmed/32095479 http://dx.doi.org/10.12793/tcp.2019.27.4.123 Text en Copyright © 2019 Nick Holford http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/). |
spellingShingle | Tutorial Holford, Nick Treatment response and disease progression |
title | Treatment response and disease progression |
title_full | Treatment response and disease progression |
title_fullStr | Treatment response and disease progression |
title_full_unstemmed | Treatment response and disease progression |
title_short | Treatment response and disease progression |
title_sort | treatment response and disease progression |
topic | Tutorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032964/ https://www.ncbi.nlm.nih.gov/pubmed/32095479 http://dx.doi.org/10.12793/tcp.2019.27.4.123 |
work_keys_str_mv | AT holfordnick treatmentresponseanddiseaseprogression |